XOMA Corp (XOMA)
25.51
-0.15
(-0.58%)
USD |
NASDAQ |
May 17, 16:00
25.34
-0.17
(-0.67%)
After-Hours: 20:00
XOMA Enterprise Value: 280.98M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 280.98M |
| May 16, 2024 | 282.73M |
| May 15, 2024 | 271.67M |
| May 14, 2024 | 281.91M |
| May 13, 2024 | 284.01M |
| May 10, 2024 | 280.17M |
| May 09, 2024 | 259.80M |
| May 08, 2024 | 265.74M |
| May 07, 2024 | 269.46M |
| May 06, 2024 | 275.28M |
| May 03, 2024 | 272.43M |
| May 02, 2024 | 280.11M |
| May 01, 2024 | 284.53M |
| April 30, 2024 | 278.95M |
| April 29, 2024 | 292.45M |
| April 26, 2024 | 279.76M |
| April 25, 2024 | 279.18M |
| April 24, 2024 | 282.44M |
| April 23, 2024 | 287.68M |
| April 22, 2024 | 284.53M |
| April 19, 2024 | 280.58M |
| April 18, 2024 | 270.22M |
| April 17, 2024 | 266.27M |
| April 16, 2024 | 267.78M |
| April 15, 2024 | 267.31M |
| Date | Value |
|---|---|
| April 12, 2024 | 284.88M |
| April 11, 2024 | 288.96M |
| April 10, 2024 | 284.07M |
| April 09, 2024 | 282.09M |
| April 08, 2024 | 277.79M |
| April 05, 2024 | 278.95M |
| April 04, 2024 | 284.30M |
| April 03, 2024 | 284.65M |
| April 02, 2024 | 290.70M |
| April 01, 2024 | 277.90M |
| March 31, 2024 | 263.94M |
| March 28, 2024 | 250.48M |
| March 27, 2024 | 242.22M |
| March 26, 2024 | 240.01M |
| March 25, 2024 | 249.90M |
| March 22, 2024 | 259.21M |
| March 21, 2024 | 256.07M |
| March 20, 2024 | 257.11M |
| March 19, 2024 | 263.86M |
| March 18, 2024 | 263.63M |
| March 15, 2024 | 276.65M |
| March 14, 2024 | 270.26M |
| March 13, 2024 | 268.40M |
| March 12, 2024 | 268.86M |
| March 11, 2024 | 276.18M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
98.41M
Minimum
Sep 13 2022
486.94M
Maximum
Dec 21 2020
204.01M
Average
187.28M
Median
Enterprise Value Benchmarks
| Societal CDMO Inc (DELISTED) | 145.26M |
| AbbVie Inc | 349.85B |
| AnaptysBio Inc | 330.21M |
| Kinnate Biopharma Inc (DELISTED) | -28.89M |
| NovaBay Pharmaceuticals Inc | 5.156M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.595M |
| Revenue (Quarterly) | 1.49M |
| Total Expenses (Quarterly) | 8.494M |
| EPS Diluted (Quarterly) | -0.86 |
| Profit Margin (Quarterly) | -576.8% |
| Earnings Yield | -15.37% |
| Normalized Earnings Yield | -11.05 |